NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31..
Quick ratio
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 39.13M USD | Liabilities, Current |
| Cash and equivalents | 9.20M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 20.59M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 29.93M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | $39.13M | $9.20M | (m) | $20.59M | $29.93M | (m) |
| 2025-12-31 | (m) | $32.85M | $3.75M | (m) | $17.76M | $33.43M | (m) |
| 2025-09-30 | (m) | $33.90M | $7.74M | (m) | $18.91M | $30.65M | (m) |
| 2025-06-30 | (m) | $28.80M | $12.32M | (m) | $14.64M | $24.87M | (m) |
| 2025-03-31 | (m) | $23.31M | $10.61M | (m) | $11.65M | $26.99M | (m) |
| 2024-12-31 | (m) | $21.65M | $8.66M | (m) | $16.90M | $23.04M | (m) |
| 2024-09-30 | (m) | $24.43M | $10.16M | (m) | $17.62M | $25.93M | (m) |
| 2024-06-30 | (m) | $23.46M | $11.98M | (m) | $16.89M | $24.25M | (m) |
| 2024-03-31 | (m) | $13.65M | $12.41M | (m) | $11.22M | $21.07M | (m) |
| 2023-12-31 | (m) | $13.41M | $16.59M | (m) | $10.46M | $19.60M | (m) |
| 2023-09-30 | (m) | $15.44M | $16.75M | (m) | $9.75M | $23.30M | (m) |
| 2023-06-30 | (m) | $15.88M | $13.60M | (m) | $7.02M | $29.69M | (m) |
| 2023-03-31 | (m) | $25.57M | $15.56M | (m) | $7.61M | $39.31M | (m) |
| 2022-12-31 | (m) | $18.55M | $12.77M | (m) | $10.28M | $36.04M | (m) |
| 2022-09-30 | (m) | $26.78M | $12.34M | (m) | $14.82M | $39.99M | (m) |
| 2022-06-30 | (m) | $23.26M | $21.83M | (m) | $17.42M | $32.48M | (m) |
| 2022-03-31 | (m) | $24.37M | $18.57M | (m) | $16.74M | $36.80M | (m) |
| 2021-12-31 | (m) | $16.49M | $19.35M | (m) | $15.06M | $31.83M | (m) |
| 2021-09-30 | (m) | $20.62M | $20.03M | (m) | $20.25M | $31.71M | (m) |
| 2021-06-30 | (m) | $22.07M | $32.13M | (m) | $17.95M | $27.01M | (m) |
| 2021-03-31 | (m) | $23.40M | $28.09M | (m) | $16.88M | $29.09M | (m) |
| 2020-12-31 | (m) | $32.69M | $28.63M | (m) | $17.06M | $34.47M | (m) |
| 2020-09-30 | (m) | $37.13M | $27.37M | (m) | $19.17M | $35.16M | (m) |
| 2020-06-30 | (m) | $27.81M | $30.48M | (m) | $17.00M | $27.97M | (m) |
| 2020-03-31 | (m) | $25.80M | $33.31M | (m) | $12.38M | $26.11M | (m) |
| 2019-12-31 | (m) | $11.20M | $26.90M | (m) | $14.23M | $22.65M | (m) |
| 2019-09-30 | (m) | $14.94M | $28.50M | (m) | $13.75M | $24.84M | (m) |
| 2019-06-30 | (m) | $14.25M | $25.04M | (m) | $15.96M | $26.00M | (m) |
| 2019-03-31 | (m) | $18.21M | $27.66M | (m) | $16.79M | $27.02M | (m) |
| 2018-12-31 | (m) | $14.62M | $30.27M | (m) | $13.54M | $23.48M | (m) |
| 2018-09-30 | (m) | $15.42M | $27.61M | (m) | $12.73M | $24.97M | (m) |
| 2018-06-30 | (m) | $14.28M | $23.61M | (m) | $14.62M | $23.57M | (m) |
| 2018-03-31 | (m) | $20.81M | $27.62M | (m) | $11.32M | $23.79M | (m) |
| 2017-12-31 | (m) | $19.21M | $28.84M | (m) | $12.89M | $17.88M | (m) |
| 2017-09-30 | (m) | $17.20M | $27.71M | (m) | $9.21M | $19.00M | (m) |
| 2017-06-30 | (m) | $10.27M | $27.84M | (m) | $8.41M | $13.73M | (m) |
| 2017-03-31 | (m) | $8.64M | $22.59M | (m) | $7.92M | $15.97M | (m) |
| 2016-12-31 | (m) | $11.46M | $21.36M | (m) | $9.84M | $17.07M | (m) |
| 2016-09-30 | (m) | $17.80M | $17.85M | (m) | $12.57M | $23.31M | (m) |
| 2016-06-30 | (m) | $19.20M | $19.75M | (m) | $13.22M | $20.77M | (m) |
| 2016-03-31 | (m) | $14.20M | $16.30M | (m) | $12.37M | $19.73M | (m) |
| 2015-12-31 | (m) | $12.68M | $22.63M | (m) | $7.57M | $18.22M | (m) |
| 2015-09-30 | (m) | $10.75M | $16.44M | (m) | $9.37M | $18.79M | (m) |
| 2015-06-30 | (m) | $9.09M | $18.55M | (m) | $9.89M | $12.56M | (m) |
| 2015-03-31 | (m) | $8.64M | $19.42M | (m) | $7.95M | $11.70M | (m) |
| 2014-12-31 | (m) | $6.76M | $20.12M | (m) | $4.70M | $12.61M | (m) |
| 2014-09-30 | (m) | $7.73M | $16.40M | (m) | $7.89M | $13.06M | (m) |
| 2014-06-30 | (m) | $9.60M | $19.51M | (m) | $6.83M | $12.84M | (m) |
| 2014-03-31 | (m) | $8.18M | $15.22M | (m) | $6.84M | $14.37M | (m) |
| 2013-12-31 | (m) | $6.49M | $16.41M | (m) | $5.64M | $11.78M | (m) |
| 2013-09-30 | (m) | $7.00M | $14.78M | (m) | $8.19M | $11.51M | (m) |
| 2013-06-30 | (m) | $5.94M | $16.70M | (m) | $6.61M | $10.04M | (m) |
| 2013-03-31 | (m) | $4.79M | $14.64M | (m) | $6.12M | $10.08M | (m) |
| 2012-12-31 | (m) | $4.51M | $17.00M | (m) | $3.31M | $9.43M | (m) |
| 2012-09-30 | (m) | $4.71M | $14.42M | (m) | $7.30M | $9.29M | (m) |
| 2012-06-30 | (m) | $6.84M | $14.48M | (m) | $8.75M | $8.36M | (m) |
| 2012-03-31 | (m) | $5.78M | $11.11M | (m) | $5.13M | $13.17M | (m) |
| 2011-12-31 | (m) | $6.12M | $11.19M | (m) | $4.89M | $12.69M | (m) |
| 2011-09-30 | (m) | $7.37M | $13.63M | (m) | $6.65M | $9.07M | (m) |
| 2011-06-30 | (m) | $4.95M | $15.46M | (m) | $3.29M | $6.50M | (m) |
| 2011-03-31 | (m) | (m) | $11.89M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $10.75M | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $8.33M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $8.55M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |